Andrew Oakley, CFO of Actelion the Swiss Biotech firm, told CNBC, "Market pressures aren't going to go away but we have factored them all in and what we have seen in the first six months have confirmed we are where we thought we would be."
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT